These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 263317

  • 1. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F, Picotti GB, Massara F, Molinatti GM, Mantegazza P, Müller EE.
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [Abstract] [Full Text] [Related]

  • 2. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA, Frohman LA.
    J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interaction between the thyrotrophin-releasing hormone-induced growth hormone rise and dopaminergic drugs: studies in pathologic conditions of the animal and man.
    Müller EE, Salerno F, Cocchi D, Locatelli V, Panerai AE.
    Clin Endocrinol (Oxf); 1979 Dec; 11(6):645-56. PubMed ID: 119594
    [Abstract] [Full Text] [Related]

  • 6. Effects of CNS dopamine augmentation on stimulated prolactin secretion.
    Woolf PD, Leebaw WJ, Lee LA.
    J Clin Endocrinol Metab; 1977 Oct; 45(4):857-60. PubMed ID: 410827
    [Abstract] [Full Text] [Related]

  • 7. Dopaminergic regulation of growth hormone (GH) secretion in normal man: correlation of L-dopa and dopamine levels with the GH response.
    Bansal S, Lee LA, Woolf PD.
    J Clin Endocrinol Metab; 1981 Aug; 53(2):301-6. PubMed ID: 7251816
    [No Abstract] [Full Text] [Related]

  • 8. Surgical cure of prolactinoma reverses abnormal prolactin repsonse to carbidopa/L-dopa.
    Molitch ME, Goodman RH, Post KD, Biller BJ, Moses AC, King LW, Feldman ZT, Reichlin S.
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1118-23. PubMed ID: 7130339
    [Abstract] [Full Text] [Related]

  • 9. Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue.
    Peracchi M, Molteni N, Cantalamessa L, Bardella MT, Peracchi G, Orsatti A, Faggioli P, Bianchi PA.
    Am J Gastroenterol; 1992 May; 87(5):580-3. PubMed ID: 1595643
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F, Cesselin F, Bression D, Zygelman N, Brandi AM, Nousbaum A, Mauborgne A.
    J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
    [Abstract] [Full Text] [Related]

  • 12. Integrity of central dopaminergic system in women with postpartum hyperprolactinemia.
    Rao R, Scommegna A, Frohman LA.
    Am J Obstet Gynecol; 1982 Aug 15; 143(8):883-7. PubMed ID: 7102764
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of dopamine agonist (Lergotrile mesylate) therapy on twenty-four hour secretion of prolactin in treated Parkinson's disease.
    Bell RD, Carruth A, Rosenberg RN, Boyar RM.
    J Clin Endocrinol Metab; 1978 Oct 15; 47(4):807-11. PubMed ID: 45469
    [Abstract] [Full Text] [Related]

  • 15. The pituitary-thyroid axis in acromegaly.
    Eskildsen PC, Kruse A, Kirkegaard C.
    Horm Metab Res; 1988 Dec 15; 20(12):755-7. PubMed ID: 3146541
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Benserazide effects on growth hormone, prolactin, and thyrotropin in normal and acromegalic man.
    Masturzo P, De Maria A, Murialdo G, Bonura ML, Zauli C, Polleri A.
    J Clin Endocrinol Metab; 1985 Aug 15; 61(2):378-81. PubMed ID: 4008612
    [Abstract] [Full Text] [Related]

  • 18. [The correlationship between basal prolactin levels and the suppressive effect of CB-154 or L-DOPA on GH release in acromegalic patients (author's transl)].
    Hara I, Kataoka K, Tomita A, Takanohashi M, Nakane T, Kuwayama A, Kageyama N.
    Nihon Naibunpi Gakkai Zasshi; 1979 Jan 20; 55(1):16-24. PubMed ID: 581754
    [Abstract] [Full Text] [Related]

  • 19. Effect of pyridoxine on human hypophyseal trophic hormone release: a possible stimulation of hypothalamic dopaminergic pathway.
    Delitala G, Masala A, Alagna S, Devilla L.
    J Clin Endocrinol Metab; 1976 Mar 20; 42(3):603-6. PubMed ID: 1254699
    [Abstract] [Full Text] [Related]

  • 20. Naloxone influence on the growth hormone, prolactin and thyrotropin response to thyrotropin releasing hormone in acromegalic patients.
    De Marinis L, Mancini A, Zuppi P, Fiumara C, Conte G, Sammartano L, Fabrizi ML, Valle D.
    Exp Clin Endocrinol Diabetes; 1996 Mar 20; 104(1):67-71. PubMed ID: 8750573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.